Literature DB >> 33760866

Prevalence of oncogenic human papillomavirus (HPV 16/18) infection, cervical lesions and its associated factors among women aged 21-49 years in Amhara region, Northern Ethiopia.

Minwuyelet Maru Temesgen1, Tefera Alemu1, Birtukan Shiferaw1, Seid Legesse1, Taye Zeru2, Mahteme Haile2, Tesfaye Gelanew3.   

Abstract

BACKGROUND: Human papillomavirus (HPV) infection is considered as the major risk factor for the development of cervical cancer, second most frequent cancer in Ethiopia. However, the magnitude of the problem and the associated factors remain unrevealed in the Amhara region. This study aimed to determine the prevalence of HPV infection and factors contributing to the progression of HPV infection to cervical cancer.
METHODS: Facility-based cross-sectional study design was employed among women aged 21 to 49 years of age who came for routine cervical cancer screening to 4 randomly selected hospitals (2 general and 2 referral) of Amhara region from May to October, 2019. The sample size was calculated by using the single population proportion formula, proportionated to hospitals, and women were recruited consecutively. Socio demographic and clinical data were collected using a pretested questionnaire and detection of HPV infection was done using HPV test (OncoE6TM Cervical Test) specific to HPV16/18 in cervical swabs. Visual inspection with acetic acid (VIA) was used to determine cervical lesions (precancerous and cancerous). Descriptive statistics and bivariate and multivariate logistic regression were used to describe HR-HPV and cervical lesions burden and association between HR-HPV, and cervical lesions and potential risk factors.
RESULTS: Among 337 women 21 to 49 years (median age of 35 years ±SD = 7.1 years) of age enrolled in the study, The overall prevalence of oncogenic HPVs (HPV16/18) and the VIA-positivity rate, possible an indicative of cervical lesions, were 7.1% and 13.1%, respectively. Logistic regression analysis showed a significant association between early age of first sexual intercourse (COR = 2.26; 95% CI: 1.0-5.05) and level of education (COR = 0.31; 95% CI: 0.12-0.78) with cervical lesions. Higher odds of HPV positivity (COR = 1.56; 95% CI: 0.59-4.11, p = 0.36) and VIA positivity (COR = 1.39; 95% CI: 0.64-3.00, p = 0.39) were observed among participants who had a history of sexually transmitted illnesses (STIs).
CONCLUSIONS: There was a relatively low prevalence of oncogenic HPV 16/18 and VIA-positivity in women attending four hospitals in the Amhara Region. Early age sexual contact, high parity, and being uneducated/low level of education were independently associated factors with HR-HPV infection and development of cervical lesions, highlighting the importance of prioritizing the limited HPV testing to those risk groups.

Entities:  

Year:  2021        PMID: 33760866      PMCID: PMC7990306          DOI: 10.1371/journal.pone.0248949

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  36 in total

1.  Cancer of the cervix: Early detection and cost-effective solutions.

Authors:  Lynette Denny; Walter Prendiville
Journal:  Int J Gynaecol Obstet       Date:  2015-02-27       Impact factor: 3.561

2.  Asymptomatic genital infection of human papillomavirus in pregnant women and the vertical transmission route.

Authors:  Dongrui Deng; Liangzhen Wen; Wen Chen; Xiazhen Ling
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia.

Authors:  A Bekele; M Baay; Z Mekonnen; S Suleman; S Chatterjee
Journal:  Trop Med Int Health       Date:  2010-06-09       Impact factor: 2.622

4.  Cervical screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy in Fiji.

Authors:  James Fong; Rajaneshwar Gyaneshwar; Sophia Lin; Stephen Morrell; Richard Taylor; Ann Brassil; Anne Stuart; Catherine McGowan
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.

Authors:  Marc Arbyn; Rengaswamy Sankaranarayanan; Richard Muwonge; Namory Keita; Amadou Dolo; Charles Gombe Mbalawa; Hassan Nouhou; Boblewende Sakande; Ramani Wesley; Thara Somanathan; Anjali Sharma; Surendra Shastri; Parthasarathy Basu
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

Review 6.  Association of Genital Infections Other Than Human Papillomavirus with Pre-Invasive and Invasive Cervical Neoplasia.

Authors:  Ishita Ghosh; Ranajit Mandal; Pratip Kundu; Jaydip Biswas
Journal:  J Clin Diagn Res       Date:  2016-02-01

7.  Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study.

Authors:  Zewdie Mulissa Deksissa; Fessahaye Alemseged Tesfamichael; Henok Assefa Ferede
Journal:  BMC Res Notes       Date:  2015-10-29

8.  Cervical Cancer Screening Service Uptake and Associated Factors among Age Eligible Women in Mekelle Zone, Northern Ethiopia, 2015: A Community Based Study Using Health Belief Model.

Authors:  Hinsermu Bayu; Yibrah Berhe; Amlaku Mulat; Amare Alemu
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

9.  Burden of cervical cancer and role of screening in India.

Authors:  Saurabh Bobdey; Jignasa Sathwara; Aanchal Jain; Ganesh Balasubramaniam
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec

10.  Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain.

Authors:  Xavier Castellsagué; Teresa Drudis; Maria Paz Cañadas; Anna Goncé; Ramón Ros; José M Pérez; M Jesús Quintana; Jesús Muñoz; Ginesa Albero; Silvia de Sanjosé; F Xavier Bosch
Journal:  BMC Infect Dis       Date:  2009-05-27       Impact factor: 3.090

View more
  4 in total

1.  Prevalence of HPV and associated factors in a population of women living in southern Brazil.

Authors:  Ana Paula Reolon Bortolli; Indianara Carlotto Treco; Valquíria Kulig Vieira; Claudicéia Risso Pascotto; Lirane Elize Defante Ferreto; Guilherme Welter Wendt; Léia Carolina Lucio
Journal:  Braz J Microbiol       Date:  2022-10-20       Impact factor: 2.214

2.  A cross-sectional assessment of symptom burden among patients with advanced cervical cancer.

Authors:  Tolcha Kebebew; Azwihangwisi Helen Mavhandu-Mudzusi; Annah Mosalo
Journal:  BMC Palliat Care       Date:  2021-12-18       Impact factor: 3.234

3.  HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women.

Authors:  Mwiza Gideon Singini; Elvira Singh; Debbie Bradshaw; Wenlong Carl Chen; Melitah Motlhale; Abram Bunya Kamiza; Chantal Babb de Villiers; Mazvita Muchengeti; Christopher G Mathew; Robert Newton; Noemi Bender; Tim Waterboer; Freddy Sitas
Journal:  Infect Agent Cancer       Date:  2022-03-29       Impact factor: 2.965

4.  Disease progression role as well as the diagnostic and prognostic value of microRNA-21 in patients with cervical cancer: A systematic review and meta-analysis.

Authors:  Alemu Gebrie
Journal:  PLoS One       Date:  2022-07-27       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.